Biologic Therapies

London, United Kingdom, May 25, 2026 The global market for CGRP inhibitors, one of the fastest-growing classes of migraine...

Houston, Texas — February 10, 2026: FibroBiologics, Inc., a clinical-stage biotechnology company advancing fibroblast-based therapeutics, announced that its Chairman...